Clinical judgment for each animal
The veterinarian looks at symptoms, history and current condition and decides whether a treatment approach applies.
MARU / TREATMENT IN DEPTH
Understanding the direction of treatment
in greater depth.
Telomere · Chamber · Quantum-related treatment approaches.
We look at how treatment for companion animals is reviewed, and at the scientific background behind it.
THE WHOLE PICTURE
Treatment · Analysis · Observation.
We look at all three together.
Treatment of companion animals is at the heart of Maru. We link test information to clinical care that looks at symptoms and history, and review together whether a treatment approach applies and how the animal progresses afterward.
Understanding measurements and results
We look at what information the specialized lab’s analysis provides and how far it can be interpreted.
Progress over time
We record changes in activity, daily life and clinical information along with test results, and look at each type of record separately.
01 / TELOMERE
Telomeres:
a starting point for understanding cells.
Telomeres are repetitive DNA sequences at the ends of chromosomes. They are involved in protecting and maintaining chromosome ends, and telomerase is the enzyme that synthesizes telomere DNA.
Put simply,
it is the study of the structure that protects chromosome ends. An individual animal’s condition is not judged by a single sentence such as “longer means healthier.”
At Maru, we explain two things separately.
Research and treatment direction
Maru’s existing materials present a companion-animal telomere research lab and anti-aging care. The purpose of a treatment approach and how it is actually applied are addressed together with clinical judgment for each animal.
A test that analyzes length
The official PetAge360 description presents telomere length analysis of an oral sample and a report. Testing is a process of obtaining information; it does not mean that the test itself is a treatment that lengthens telomeres.
Testing company’s description →What to look at when reading results
- What was collected, and how it was measured
- The animal’s age, breed and condition, and the comparison standard used
- How test values relate to actual symptoms and clinical information
- For follow-up tests, whether collection and analysis conditions are comparable
02 / CHAMBER
Equipment, including the chamber,
and the treatment process.
The chamber is one pillar of the equipment and space that Maru presents as a main treatment. Existing materials list a “CR room chamber” under the telomere research lab.
Four questions for understanding the equipment
What kind of equipment is it?
The starting point is the manufacturer and model, and the physical conditions it applies. We do not assume a specific method, such as hyperbaric oxygen or electromagnetic fields, from the name ‘chamber’ alone.
Which animals is it used for?
The target condition, the purpose of use and the veterinarian’s criteria should be looked at separately from the equipment description.
Under what conditions is it used?
Recording the conditions and process of use, observations of the animal’s response and any concurrent care is the basis for understanding the treatment process.
What is progress assessed on?
We look at the condition before and after the equipment is used, symptoms and function, and clinical records together. We do not conclude that the equipment alone had an effect based only on the order of events.
How to understand the chamber
The principles and relevant research differ depending on the exact type of equipment. Studies of other types of chambers are not used in place of evidence for this equipment’s treatment effects.
03 / QUANTUM-RELATED APPROACH
From the name of a technology
to understanding how it is actually applied.
Maru takes Director Son Hwa-seop’s wave- and quantum-related animal treatment technology as a main direction of its clinical care. The existing brochure contains explanations of the glomus, reversibly damaged cells and energy, along with cases of animals with nerve injuries.
We look at it on three levels.
What principle does it describe?
We look at how the proposed principle connects with the way the actual equipment works.
What was tested?
We look at which animals, conditions and settings were studied, and whether there were control groups and measured results.
What was observed?
We look at how each animal’s care, concurrent treatments and changes in function and symptoms were recorded.
The existence of quantum mechanics as a general theory and the effect of a specific device in treating animals are separate matters. We present Maru’s technology descriptions, animal cases and external research separately, according to what each one actually supports.
View Maru animal cases in detail →SCIENCE BEHIND THE QUESTION
The scientific reasons
behind telomeres.
Cell principles, observational animal studies and experimental treatment research.
Let’s look at what the evidence does — and does not — say.
TelomereChromosome endChromosomal DNATelomereChromosome end
Diagram explaining the principle · not actual measurements or a before-and-after treatment comparison
The structure that protects chromosome ends
Telomeres are repetitive DNA sequences at the ends of chromosomes, and telomerase is the enzyme that synthesizes them. The discovery of this protection and maintenance mechanism was the subject of the 2009 Nobel Prize in Physiology or Medicine.
What this evidence tells us +
It is a basic principle for understanding cells and chromosomes. The Nobel Prize does not certify the effectiveness of any particular hospital treatment or device.
Telomeres and lifespan
A 2012 study reported an association between telomere length in blood mononuclear cells and average breed lifespan across 15 dog breeds. This is one reason telomeres are examined in animal aging research.
What this evidence tells us +
This study looks at associations at the breed level. It does not calculate an individual animal’s remaining lifespan or prove that treatment extended lifespan, and blood-study results cannot be equated with the performance of an oral-sample test product.
Experimental use of telomerase
A 2012 study delivered the telomerase gene to adult and aged mice using an AAV9 vector. Under the study conditions, improvements in some health markers and an increase in median lifespan were reported.
What this evidence tells us +
This is a specific gene therapy experiment in mice. It did not use chamber or wave equipment and cannot be taken as evidence that the same results occur in dogs, cats or Maru’s treatments.
From research to clinical care
The connection Maru aims for is research principles → test results → clinical judgment for each animal → progress records. We explain the scientific background and real-world results separately.
DISEASE CATEGORIES
Disease categories,
set out in text.
We have carried over every item from the newly received material and briefly explained what each name means.
This list explains the disease names in the material we received.
The source material mixes human disease names with different medical classifications. It is not a list of conditions Maru treats in animals, nor a list of conditions for which treatment effects have been confirmed.
01 · Mental disorders
The category title is as given in the source material.
- Autism
- A neurodevelopmental condition involving differences in social communication and patterns of behavior. Today it is mainly called ‘autism spectrum disorder.’
- Tic disorder
- A condition in which brief, unintended movements or sounds occur repeatedly.
- Hysteria
- A term formerly used broadly for a variety of symptoms. Because it does not correspond directly to any specific current diagnosis, the symptoms meant in the material need to be confirmed.
- Trauma
- Refers to a shocking experience and its psychological effects. Having experienced trauma is not the same as a diagnosis of post-traumatic stress disorder.
- Panic disorder
- A disorder in which panic attacks, such as sudden intense fear and a pounding heart, recur and are followed by ongoing worry that they will happen again.
- Schizophrenia
- A mental illness that may involve hallucinations, delusions or disorganized thinking.
- Manic depression
- Now called ‘bipolar disorder.’ It may involve periods of greatly elevated mood and activity as well as periods of depression.
- Epilepsy
- A neurological disease in which seizures recur because of abnormal electrical activity in the brain. It is not classified as a mental illness.
- Depression
- An illness in which low mood or loss of interest persists and affects sleep, appetite, concentration and daily life.
- ADHD
- A neurodevelopmental disorder in which inattention, hyperactivity or impulsivity persists and affects daily life.
02 · Autoimmune diseases
The category title is as given in the source material; not every item is an autoimmune disease.
- Lupus
- A disease in which the immune system attacks the body’s own tissues, which can cause inflammation in the skin, joints, organs and elsewhere.
- Behçet’s
- A disease in which ulcers in the mouth and genitals and inflammation of the eyes may recur. It can affect many parts of the body, including the blood vessels.
- Welson
- The name as written in the source material. It needs to be confirmed whether this means ‘Wilson’s disease.’ If so, Wilson’s disease is a genetic disorder in which copper builds up in the body, and it is not an autoimmune disease.
- Crohn’s disease
- An inflammatory bowel disease that causes chronic inflammation of the digestive tract. Symptoms such as abdominal pain and diarrhea may occur.
- Rheumatoid arthritis
- The source uses a nonstandard Korean spelling; the standard term is ‘rheumatoid arthritis.’ The immune system attacks joint tissue, causing pain, swelling and stiffness.
- Ankylosing myelitis
- As written in the source material. It needs to be confirmed whether this means ‘ankylosing spondylitis.’ If so, it is a disease that causes chronic inflammation in the spine, the pelvic joints and elsewhere.
- Sjögren’s syndrome
- The immune system attacks the tear glands, salivary glands and other glands, which may cause dry eyes and a dry mouth.
- Psoriasis & vitiligo
- Psoriasis is a disease that causes red, scaly patches on the skin. Vitiligo is a disease in which pigment cells are damaged and patches of skin turn white; the two are distinct.
- Hashimoto syndrome
- A term that generally refers to ‘Hashimoto’s thyroiditis.’ The immune system attacks the thyroid, which can lead to reduced thyroid function.
- Dermatitis, Cushing’s
- Dermatitis is a broad term for inflammation of the skin. Cushing’s syndrome is a condition with excess cortisol; the two items belong to different disease categories.
Source of disease names: newly received material. The original photo has been kept, and its content is shown here as text. The terms ‘Welson’ and ‘ankylosing myelitis’ need to be checked against the source material.
References for the explanations: US National Institute of Mental Health: health topics · Lupus · Crohn’s disease · Rheumatoid arthritis · Wilson’s disease
FROM ANALYSIS TO FOLLOW-UP
From testing to clinical care,
and on to following progress.
- We review the condition and previous records.
We put together symptoms, when the changes started, previous tests and treatments, and current medications.
- We explain what information the test provides.
We understand the test’s purpose, the items measured and the scope of interpretation, and review which analyses are needed.
- The veterinarian decides whether it applies.
The direction of treatment is reviewed based on the animal’s condition and clinical information, not on a single test value.
- We record the treatment process and concurrent care.
We distinguish what was applied, when and how, and whether other treatments or medications were involved.
- We observe changes and explain the next plan.
We review progress in activity, symptoms and function together with test information, and decide whether follow-up care is needed.
This is the flow of explanation and recording that Maru aims for. Each animal’s treatment plan depends on clinical judgment.
QUESTIONS & ANSWERS
Questions about
our core treatments.
Are the telomere test and treatment the same thing?+
No. Testing is a process of measuring information such as length. The purpose of a treatment approach and whether it applies must be explained and decided separately.
Does the mouse telomerase study prove the chamber’s effect?+
No. The mouse study on this page was an experiment in which a gene was delivered using an AAV9 vector. It was not an experiment using a chamber or wave equipment.
If test values improve, does that mean the treatment succeeded?+
We do not judge by test values alone. Measurement conditions and variability, the animal’s symptoms, function and clinical information, and concurrent treatments must all be considered together.
How should I understand the animal cases?+
They should be understood as the progress recorded for that particular animal. Individual cases alone cannot guarantee recovery for every animal or the sole effect of any specific device.
What should I prepare before a consultation?+
Previous clinical and test results, current medications, the date the changes began, and photos or videos of movement and behavior will help with the explanation.